This document is a focused update to the 2017 colorectal cancer (CRC) screening recommendations from the US Multi-Society Task Force on Colorectal Cancer, which …
NN Keum, E Giovannucci - Nature reviews Gastroenterology & …, 2019 - nature.com
Globally, colorectal cancer (CRC) is the third most commonly diagnosed malignancy and the second leading cause of cancer death. Arising through three major pathways, including …
AMD Wolf, ETH Fontham, TR Church… - CA: a cancer journal …, 2018 - Wiley Online Library
Abstract In the United States, colorectal cancer (CRC) is the fourth most common cancer diagnosed among adults and the second leading cause of death from cancer. For this …
P Wang, X Xiao, JR Glissen Brown, TM Berzin… - Nature biomedical …, 2018 - nature.com
The detection and removal of precancerous polyps via colonoscopy is the gold standard for the prevention of colon cancer. However, the detection rate of adenomatous polyps can vary …
Background The causative factors for the recent increase in early-onset colorectal cancer (EO-CRC) incidence are unknown. We sought to determine if early-onset disease is …
Objective Screening colonoscopy's effectiveness in reducing colorectal cancer mortality risk in community populations is unclear, particularly for right-colon cancers, leading to …
This article has an accompanying continuing medical education activity on page e19. Learning Objective: Upon completion of this exam, successful learners will recognize the …
DJ Ahnen, SW Wade, WF Jones, R Sifri… - Mayo Clinic …, 2014 - Elsevier
Abstract In the United States, colorectal cancer (CRC) is the third most common and second most lethal cancer. More than one-tenth of CRC cases (11% of colon cancers and 18% of …
The “serrated neoplastic pathway” describes the progression of serrated polyps, including sessile serrated adenomas and traditional serrated adenomas, to colorectal cancer. The …